公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2014 | Clinical genotyping and efficacy outcomes: Exploratory biomarker data from the phase II ABIGAIL study of first-line bevacizumab plus chemotherapy in non-squamous non-small-cell lung cancer | Pallaud C.; Reck M.; Juhasz E.; Szima B.; CHONG-JEN YU ; Burdaeva O.; Orlov S.; Hilton M.; Archer V.; Mok T. | Lung Cancer | 18 | 16 | |
2014 | A correlative biomarker analysis of the combination of bevacizumab and carboplatin-based chemotherapy for advanced nonsquamous non-small-cell lung cancer: Results of the phase II randomized ABIGAIL study (BO21015) | Mok T.; Gorbunova V.; Juhasz E.; Szima B.; Burdaeva O.; Orlov S.; CHONG-JEN YU ; Archer V.; Hilton M.; Delmar P.; Pallaud C.; Reck M. | Journal of Thoracic Oncology | 46 | 44 |